Search filters

Kuros Biosciences AG completes rights offering and share placement

Kuros Biosciences (SIX: KURN) completes a rights offering and share placement in which a total of 8,013,306 new registered shares of Kuros sourced from the ordinary and authorized share capital with a nominal value of CHF 1.00...

Swisstom acquired by Sentec

Sentec has acquired Swisstom, which has developed non-invasive, regional lung function monitoring devices based on Electrical Impedance Tomography (EIT). The focus of Swisstom will remain unchanged under the umbrella of Sentec AG....

Resistell closes seed round

Resistell has closed an oversubscribed seed financing round. Lead Investors Michal Bartos and Occident Group AG, together with Hemex AG and five other private investors invested in the EPFL spin-off developing the world’s fastest...

AFINUM successfully exits its investment in Let's Go Fitness Group

AFINUM Siebte Beteiligungsgesellschaft mbH & Co. KG has successfully exited its investment in Let's Go Fitness Group, the largest operator of fitness centers in French-speaking Switzerland, to Naxicap Partners and the management...

Axpo spins its grid business off into a new group company

The Axpo Group produces, trades and distributes energy for more than 3 million People and several thousand companies in Switzerland and in over 30 countries throughout Europe. In order to better respond to market volatility, Axpo...

TOLREMO closes Series A financing of CHF 9 million

TOLREMO therapeutics AG, a privately held Swiss biotech company and ETH Zurich Spin-Off, completed a series A financing round of CHF 9.0 million. The round was led by BioMedPartners with Redalpine and Altos Venture as well as...

Berenberg sells a majority stake of Berenberg Bank (Schweiz) AG

The Hamburg based private bank Joh. Berenberg, Gossler & Co. KG sells a majority stake in its subsidiary Berenberg (Schweiz) AG to a group of well-known entrepreneurs and the local management. The transaction is subject to the...

China Medical System Holdings invests in VAXIMM

VAXIMM AG, a company focused on developing oral T-cell immunotherapies, entered into development and commercialization collaboration agreement with and received an equity investment by China Medical System Holdings Limited (CMS)...

CRISPR Therapeutics closes public offering of USD 200m

CRISPR Therapeutics AG (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, announced on September 20, 2018 the pricing of a public offering of 4,210,526 of...

Novo REPAIR Impact Fund invests in Polyphor's antibiotic OMPTA pipeline

Novo REPAIR Impact Fund has committed to invest CHF 6.8M in Polyphor through a capital increase. In addition, the fund has committed to make a project-based, royalty-bearing investment of CHF 4.7M in cash at the achievements of...

You are currently offline. Some pages or content may fail to load.